United States — Food and Drug Administration & Marty Makary
23 shared events · Importance 3 · Last updated Aug 20, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
United States — Food and Drug Administration: The FDA is the agency being led. It faces staff losses, morale issues, and policy controversies; Overton's nomination could exacerbate these challenges.
Marty Makary: Makary resigned as FDA commissioner in May after clashes with the White House. His departure created the vacancy Overton is nominated to fill.
Aug 19, 2026 · 101 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration was directed by Donald Trump to issue new guidance on acetaminophen and approved leucovorin for autism treatment, facing scrutiny for its scientific basis.
Marty Makary: Marty Makary, the United States — Food and Drug Administration Commissioner, announced the agency's actions regarding acetaminophen and leucovorin under the Trump administration's directive.
Sep 22, 2025 · 6 articles
Regulatory
United States — Food and Drug Administration: The FDA granted approval for mFLUSIVA, marking a regulatory milestone and demonstrating its role in vaccine oversight despite internal controversies.
Marty Makary: Makary, former FDA Commissioner, faced criticism for vaccine scrutiny and resigned amid controversies.
Aug 05, 2026 · 105 articles
Regulatory
United States — Food and Drug Administration: Regulatory body that approved Lipfendra, enabling market entry.
Marty Makary: Former FDA chief who created the accelerated review pathway used for Lipfendra; resigned in May 2026.
Jul 16, 2026 · 93 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration is expected to notify doctors about a potential association between acetaminophen and autism, a recommendation that lacks immediate medical evidence and is controversial.
Marty Makary: Marty Makary, as United States — Food and Drug Administration Commissioner, announced steps to approve leucovorin as a treatment option for patients with low folate levels, potentially including some with autism.
Sep 22, 2025 · 6 articles
Domestic
United States — Food and Drug Administration: The FDA is mentioned as another agency with a leadership vacancy, but it is not directly involved in this event.
Marty Makary: Makary's resignation as FDA commissioner contributed to the leadership vacuum in health agencies.
Jul 15, 2026 · 148 articles
Business
United States — Food and Drug Administration: The FDA granted Breakthrough Therapy Designation to BPL-003 and announced regulatory actions to support psychedelic drug development, facilitating the path to market.
Marty Makary: Marty Makary, former FDA commissioner, commented on the FDA's regulatory actions supporting psychedelic therapeutics.
Jul 16, 2026 · 25 articles
Business
Marty Makary: FDA Commissioner Marty Makary, alongside Robert F. Kennedy Jr., announced steps to eliminate synthetic dyes, supporting the broader regulatory push for cleaner food ingredients.
Oct 01, 2025 · 7 articles
Regulatory
Marty Makary: As Food and Drug Commissioner, Marty Makary signaled the administration's stance on saturated fats and commented on protein guidance.
Jan 07, 2026 · 7 articles
Regulatory
Marty Makary: As the Commissioner of the United States — Food and Drug Administration, Marty Makary is a key figure in implementing the new policy to reduce the number of required studies for drug approval, aiming to speed up drug development.
Feb 18, 2026 · 6 articles
International
Marty Makary: Marty Makary is resigning as the head of the United States — Food and Drug Administration due to difficulties and complaints from health industry executives, anti-abortion activists, and other Trump allies.
May 12, 2026 · 18 articles
International
Marty Makary: Marty Makary resigned as the head of the United States — Food and Drug Administration after a rocky tenure and complaints from various industry groups.
Apr 16, 2026 · 760 articles
Regulatory
Marty Makary: Marty Makary resigned as United States — Food and Drug Administration Commissioner, having engineered Tracy Beth Høeg's rapid rise and facing criticism from political allies.
May 15, 2026 · 17 articles
International
Marty Makary: Marty Makary resigned as the United States — Food and Drug Administration Commissioner, contributing to the agency's leadership upheavals.
May 12, 2026 · 17 articles
Domestic
Marty Makary: Marty Makary resigned as head of the United States — Food and Drug Administration, widening the leadership gap within the United States — United States Department of Health and Human Services and leaving behind unfinished initiatives.
May 13, 2026 · 6 articles
Domestic
Marty Makary: Marty Makary>>> resigned as Commissioner of the United States — Food and Drug Administration>>> after a tumultuous tenure marked by clashes with the Donald Trump>>> administration, industry, and public health groups. His departure creates uncertainty for several of his initiatives.
May 08, 2026 · 114 articles
International
Marty Makary: Marty Makary is resigning as the head of the United States — Food and Drug Administration after a rocky tenure, drawing complaints from various industry executives and activists.
Apr 30, 2026 · 116 articles
Regulatory
Marty Makary: Former United States — Food and Drug Administration Commissioner Marty Makary had indicated that reviewing the benefits of MDMA and other psychedelics was a top priority, though his resignation may impact the pace of review.
May 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Marty Makary interact across events, view sentiment trends, and discover connected entities.
Open Dashboard